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Abstract: Visceral leishmaniasis (VL) is the most severe form of leishmaniasis caused by protozoan 
parasites of the genus Leishmania. Hepatomegaly is one of the most frequent clinical manifestations 
of VL, whereas immunopathology of the symptom has not been well investigated. Using our 
chronic model of experimental VL, we examined the influence of Leishmania donovani infection on 
the liver by clinical, histological, and biochemical analyses. The infected mice showed increased 
liver weight 24 weeks post-infection. Although an increase in serum ALT and inflammatory cell 
accumulation were observed in the livers of infected mice, no apparent parenchymal necrosis or 
fibrosis was observed. Tissue water content analyses demonstrated that increased liver weight was 
predominantly due to an increase in water weight. Together with the finding of hepatic sinusoidal 
dilation, these results suggested that edema associated with sinusoidal dilation causes hepatomeg-
aly in L. donovani infection. Immunostaining of platelets and erythrocytes showed no thrombus for-
mation or damage to the sinusoidal endothelium in the liver of infected mice. Taken together, these 
results suggest that hepatomegaly during experimental VL is caused by non-obstructive sinusoidal 
dilation. 
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1. Introduction 
Leishmaniasis is one of the neglected tropical diseases and is estimated to affect 0.7-
1 million people annually [1]. It typically presents in either the visceral, cutaneous, or mu-
cocutaneous forms. Of these, the visceral form, also known as visceral leishmaniasis (VL) 
or kala-azar, is known to show the most severe clinical disease. In 2019, more than 90% of 
new cases reported to the WHO occurred in ten countries: Brazil, Ethiopia, Eritrea, India, 
Iraq, Kenya, Nepal, Somalia, South Sudan, and Sudan [1]. Symptoms of VL include en-
largement of the spleen and liver, pancytopenia, fever, and loss of body weight, which 
endanger the patients’ lives [1]. Among all the Leishmania species, Leishmania donovani and 
Leishmania infantum are well known to infect internal organs and cause VL . 
Enlargement of the liver (hepatomegaly) is a common symptom in VL patients; 30–
100% of VL patients with parasitological confirmation present with liver enlargement [2–
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11]. In addition, biochemical markers of hepatocellular damage, AST and ALT, are found 
to be elevated in the blood of these patients [2,9–12]. Moreover, it has been reported that 
liver failure may be a direct cause of death in VL patients [13]. Because hepatomegaly is 
the most common finding in the liver of VL patients, elucidation of the mechanism by 
which this occurs will be a good start to understanding various influences that the para-
sites have on the liver, potentially including portal hypertension and hepatocyte necrosis. 
However, there are currently a limited number of papers in the literature describing his-
tological changes of the liver in human patients in detail, reporting hyperplasia of Kupffer 
cells and hepatocytes or fatty change of hepatocytes [14,15]. 
Although experimental models of VL are useful to study protective responses against 
Leishmania infection, they have received less attention as a tool for studying the immuno-
pathology of VL. Despite the fact that hepatic abnormalities are characteristics of chronic 
disease in human VL patients [13], much research has focused not on experimental repro-
duction of such manifestations of chronic VL, but rather on granuloma-mediated protec-
tive immunity in the liver during the first four to eight weeks of experimental infection 
[16–18]. The latter models often use a combination of C57BL/6 mice as hosts and Leishma-
nia amastigotes as infecting pathogens, and result in self-limiting liver infection with a 
peak parasite burden at approximately four weeks post-infection [19,20]. Hamster models 
of experimental VL generally show more severe pathology than mouse models, making 
hamsters more suitable for pathological research on VL. However, hamsters do not nec-
essarily develop hepatomegaly during experimental VL [21]. In contrast, we have devel-
oped a mouse model of VL showing sustained parasite infection in the liver associated 
with non-healing hepatomegaly for up to six months [22]. Our mouse model showing 
prolonged hepatomegaly may be useful for studying the immunopathology of not acute, 
but rather chronic and sustained hepatomegaly found in VL patients. 
In general, hepatomegaly is caused by various mechanisms, including congestion, 
portal hypertension, and hepatocyte hypertrophy [23]. These are secondary to changes in 
the liver on the organ, tissue or cellular levels, though yet to be determined in the case of 
VL. Therefore, we examined the structural and functional changes in the liver to better 
understand the pathogenesis of hepatomegaly in our experimental model of VL. 
2. Results 
2.1. Hepatic Changes Induced by Long-Term Infection with L. donovani in Mice 
As previously reported [22], six months infection with L. donovani in BALB/cA mice 
induced a significant increase in the weight of the spleen and liver at 24 weeks post-infec-
tion, whereas no apparent change in body weight was induced by the infection (Figure 
1A). The mean liver weight of the infected mice at 24 weeks post-infection was 31% higher 
than that of uninfected mice (Figure 1A). Hepatomegaly was not apparent in L. donovani-
infected BALB/cA mice at 12 weeks post-infection, while the mean spleen weight of the 
infected mice was around three times as high as that of naive mice at this time point (Fig-
ure 1A). Parasite burdens in the spleen of infected mice showed a significant increase from 
12 weeks to 24 weeks post-infection, whereas liver parasite burdens were equivalent be-
tween the two time points (Figure 1B). Hepatosplenomegaly caused by L. donovani infec-
tion was suppressed in nude mice even at 24 weeks post-infection (Figure 1C). Liver LDU 
of nude mice at 24 weeks post-infection (825 ± 623) was equivalent to BALB/cA mice at 
the same time point of infection. Serum biochemical tests demonstrated a marked increase 
in total protein in 24-week-infected BALB/cA mice, mainly due to an increase in globulins, 
but not albumin; serum albumin levels were rather lower in the infected mice (Figure 1D). 
Serum from the infected mice also contained mildly elevated levels of liver enzyme ALT 
(Figure 1D). The concentration of serum triglycerides was not significantly different be-
tween the uninfected and infected groups at 24 weeks of infection (Figure 1D). Any of the 
changes found in the infected mice at 24 weeks post-infection were not evident at 12 weeks 
post-infection (Figure1D). Histological analyses of the liver of the 24-week-infected 
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BALB/cA mice showed vasculitis in the portal veins and granuloma formation (Figure S2). 
In contrast, no apparent parenchymal necrosis or fibrosis, and no apparent changes in the 
number of KI-67-positive hepatocytes was observed in the infected liver (Figure S2). 
 
Figure 1. Hepatomegaly in a mouse model of chronic VL. (A) Body weights, spleen weights, and liver weights of naive 
BALB/cA mice (n = 5) and L. donovani-infected BALB/cA mice (n = 5 or 6) at 12 and 24 weeks post-infection. (B) Spleen and 
liver LDU of L. donovani-infected BALB/cA mice at 12 and 24 weeks post-infection. (C) Spleen weights and liver weights 
of naive nude mice (n = 5) and L. donovani-infected nude mice (n = 4) at 24 weeks post-infection. (D) Serum levels of 
indicated molecules in naive BALB/cA mice (n = 5 or 10) and L. donovani-infected BALB/cA mice (n = 5 or 10) at 12 and 24 
weeks post-infection. Bars represent the means of individual groups. *p < 0.05; **p < 0.01; ****p < 0.0001; ns, not significant 
by unpaired t test (C) or two-way ANOVA with Sidak's multiple comparisons test (A, D). This is a representative of three 
independent experiments with similar results. 
The significant increase in weight, as well as the change in serum ALT levels, indi-
cated structural and functional changes of the liver of the 24-week-infected BALB/cA mice. 
To investigate metabolic changes in the liver of the infected mice, PAS staining and Oil 
red-O staining were performed on tissue sections to visualize glycogen and triglyceride 
storage, respectively. PAS staining in naive mice showed that the cytoplasm of many 
hepatocytes was filled with granular structures that stained reddish purple, whereas there 
were fewer stained cells in the liver of the infected mice, and the bodies stained in these 
cells were only sparsely present in the cytoplasm (Figure 2A). Quantification of the PAS 
staining intensity showed that the signal was significantly weaker in the liver of the in-
fected mice than that of naive mice (Figure 2B). Although TG index showed a statistical 
difference between naive and infected mouse livers, the values were very low in both 
groups, and Oil red-O staining microscopically showed no fat droplets in either naive or 
infected mouse livers (Figure 2C, D). 




Figure 2. Decreased glycogen storage in the liver during experimental VL. (A) PAS-stained liver 
tissues from naive and L. donovani-infected BALB/cA mice at 24 weeks post-infection (n = 5 for each 
group). Scales, 50 μm. (B) Glycogen index, quantification of PAS staining intensity for liver tissues 
of naive and infected mice. (C) Oil Red O-stained liver tissues from naive and L. donovani-infected 
BALB/cA mice at 24 weeks post-infection (n = 5 for each group). Scales, 50 μm. (D) TG index, quan-
tification of Oil Red O staining intensity for liver tissues of naive and infected mice. Bars represent 
the means of individual groups. **p < 0.01 by unpaired t test. This is representative of three inde-
pendent experiments with similar results. 
2.2. Hepatic Edema Due to Sinusoidal Dilation in L. donovani Infection 
To address the mechanisms for increased liver weight in BALB/cA mice infected with 
L. donovani at 24 weeks post-infection, water content of the liver from the uninfected and 
infected mice was examined. The water content of the infected liver was 70% and was 
significantly higher than that of naive mice (68%). Increased water weight (0.40 g), rather 
than dry weight (0.12 g), predominantly accounted for the increased whole liver weight 
(0.52 g) induced by L. donovani infection (Figures 1C and 3). On the other hand, changes 
in water content, water weight, or dry weight of the liver were not apparent at 12 weeks 
post-infection (Figure 3). 
 
Figure 3. Increased water content in the liver of L. donovani-infected BALB/cA mice. Pieces of liver 
from naive and L. donovani-infected BALB/cA mice (n = 5 for each group) at 12 and 24 weeks post-
infection were weighed before and after a drying process. Water content (A), water weight (B), and 
dry weight (C) of the whole liver were then calculated. Bars represent the means of individual 
groups. ***p < 0.001; ****p < 0.0001 by two-way ANOVA with Sidak's multiple comparisons test. 
Histological observations did not reveal any apparent hepatocyte hypertrophy in the 
24-week-infected liver. Next, to seek out other mechanisms to explain the water increase 
in L. donovani infection, blood vessel dilation was looked for histologically. Image analyses 
of area occupancy by arteries, central veins, portal veins, and bile ducts demonstrated no 
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dilation in any of these in L. donovani infection (Figure 4A). On the other hand, area occu-
pancy by sinusoids was high in the liver of the infected mice at 24 weeks post-infection 
(Figure 4A). Conversely, the area occupied by hepatocytes was lower in the infected liver, 
and this decline was also accompanied by a decrease in the number of hepatocyte nuclei 
(Figure 4B, C). The hepatocyte index, an indicator of the average size of hepatocytes, was 
comparable between the uninfected and infected mice (Figure 4D), indicating that in-
creased sinusoidal space is not due to shrinkage of hepatocytes. 
Further histological analyses did not demonstrate any obvious venous obstruction. 
Immunohistochemical staining of erythrocytes and platelets did not show increased ag-
gregation of either within sinusoids of the infected liver (Figure S3), suggesting that 
thrombus formation and subsequent sinusoidal obstruction are unlikely. Platelets also did 
not extravasate into the space of Disse in the infected liver, suggesting minimal damage 
to the sinusoidal endothelia. 
 
Figure 4. Sinusoidal dilation in BALB/cA mice with L. donovani infection. (A, B) Representative images of H&E-stained 
liver sections of naive (A) and L. donovani-infected BALB/cA mice at 24 weeks post-infection (B). Sinusoidal dilation in the 
infected liver was prominent. Scales, 20 μm. (C) Area occupancy by central veins, portal veins, hepatic arteries, bile ducts, 
and sinusoids in the liver of naive (n = 5) and L. donovani-infected BALB/cA mice (n = 6) at 24 weeks post-infection was 
histologically analyzed. (D) Area occupancy by hepatocytes and other cells in the liver of naive and L. donovani-infected 
BALB/cA mice at 24 weeks post-infection was histologically analyzed. Bars represent the means and SDs of individual 
groups. **p < 0.01; ****p < 0.0001; ns, not significant by two-way ANOVA with Sidak's multiple comparisons test. (E) The 
average numbers of hepatocytes and other cells per field in the liver of naive and L. donovani-infected BALB/cA mice were 
histologically analyzed. (F) Hepatocyte index, which is an indicator of hepatocyte cell size, is shown. Bars represent mean 
± SD of individual groups. *p < 0.05; ns, not significant by unpaired t test. 
3. Discussion 
Hepatomegaly is one of the major clinical manifestations of VL. Using a mouse model 
of L. donovani infection with long-term persistence of the parasites in the liver, we demon-
strated that hepatomegaly during chronic VL is caused by edema accompanied with si-
nusoidal dilation. Increased liver weight during L. donovani infection in BALB/cA mice 
was significant at 24 weeks of infection but not at 12 weeks (Figure 1). On the other hand, 
liver parasite burdens were equally high at 12 and 24 weeks post-infection, suggesting 
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that hepatomegaly is not just a reflection of parasite burden in the liver. The water content 
of the liver increased from 68 to 70% in 24-week-infected mice and this increase in water 
weight accounted for the majority of the increase in whole liver weight (Figure 3). While 
accelerated proliferation or hypertrophy of hepatocytes was not evident in the infected 
liver when analyzed (Figure 4, Figure S2), sinusoidal dilation was remarkable in the in-
fected tissue, suggesting that the mass of extracellular fluid, rather than cellular mass, 
contributed to the increase in liver weight in L. donovani infection. It is intriguing that 
vascular dilation was unique to sinusoids: no obvious dilation of central or portal veins 
was found and no apparent emboli were detected in any of the sinusoids, central veins, 
or portal veins of the liver of infected mice (Figure 4). Hepatocyte shrinkage was also not 
detected (Figure 4), and serum levels of AST and ALT were unchanged or only mildly 
elevated in infected mice (Figure 1), suggesting that the dilation of sinusoids does not 
result from damage to hepatocytes and may be induced by mechanisms directly targeted 
to the hepatic sinusoids. Sinusoidal dilation, as found in our experimental model, has also 
been reported by another group in L. donovani-infected C57BL/6 mice [20], suggesting that 
this pathological change is not restricted by the genetic background of mice. 
Lima et al. have previously reported histological alterations in the liver of dogs natu-
rally infected with L. infantum [24], and many of the alterations found in dogs, including 
portal inflammation and granuloma formation, were shared with the findings of our 
study. Portal inflammation has also been reported in human VL with a high prevalence 
[14]. Low frequencies of sinusoidal congestion, hepatocyte steatosis, and hepatocyte ne-
crosis were also found in the dogs [24], with similar patterns to the mice in this study. In 
humans, Datta et al. reported sinusoidal dilation in the liver of a VL patient [25]. Prasad et 
al. also reported a high prevalence of sinusoidal dilation in liver of VL patients [26]. How-
ever, such studies on liver histology in human VL are very limited, and it is difficult to 
estimate the true prevalence of hepatic sinusoidal dilation during the disease. In dogs, 
sinusoidal dilation was found only in ~20% of VL cases [24]. The low prevalence may 
suggest that sinusoidal dilation is a characteristic of not mild but severe VL. Hepatomeg-
aly itself may also be an indicator of more advanced VL as its prevalence in human cases 
is generally lower than that of anemia or splenomegaly [2,3,6,7,27]. In our study, hepato-
megaly accompanied by an increase in water weight became evident at 24 weeks post 
infection in mice, but not 12 weeks (Figures 1 and 3). At 12 weeks post-infection, the spleen 
weight of infected mice was already three times as high as that of naive mice (Figure 1), 
demonstrating a delayed onset of hepatomegaly relative to splenomegaly. 
It was revealed that hepatomegaly and splenomegaly, the two organomegalies evi-
dent during VL, are immune-mediated as these disease manifestations were not seen in 
nude mice with L. donovani infection (Figure 1). In fact, El Hag et al. also indicated immu-
nological etiology of liver pathology in VL based on their clinical findings [14]. Hepato-
megaly appears to be less common in HIV-coinfected VL patients than HIV-negative VL 
patients [28], and Ramos et al. showed that the incidence of hepatomegaly in VL was even 
lower in immunosuppressed individuals than those with HIV coinfection [29]. However, 
mechanisms for the enlargement of spleen and liver during experimental VL may be quite 
different and these organomegalies may occur as independent events. Firstly, splenomeg-
aly during experimental VL is accompanied by an increase in cell numbers [30], whilst 
hepatomegaly is not - as demonstrated in the present study. Secondly, our previous stud-
ies using genetically modified mice demonstrated that deficiency in host molecules BAFF 
and MRP14 leads to attenuation of splenomegaly, but not hepatomegaly, in L. donovani 
infection [30,31]. Although it is known that dysfunction or damage in the liver or the 
spleen often affects the other, the influence of L. donovani infection on these organs does 
not appear very closely connected. Carrion et al. demonstrated that the liver weight in L. 
infantum-infected BALB/cA mice continued to increase at day 56 of infection, whilst liver 
parasite burden peaked at day 14 [32]. Along with our data in nude mice, it should be 
noted that hepatomegaly in experimental VL is not necessarily associated with an increase 
in parasite burden. 
Pathogens 2021, 10, 1356 7 of 12 
 
 
There are several models of hepatic sinusoidal dilation. Marzano et al. proposed pos-
sible causes as obstruction of the sinusoids or central veins, including thrombosis due to 
damage to the sinusoidal endothelium, and non-obstructive mechanisms including 
hepatocyte shrinkage, increased inflow of blood, and an increase in soluble factors, which 
induce sinusoidal dilation [33]. One of the best known is sinusoidal obstruction; sinusoi-
dal obstruction syndrome is caused by swelling and detachment of the sinusoidal endo-
thelium, leading to hypercoagulability and obstruction of the sinusoids [33]. Aberrant 
production of immunoglobulins during experimental VL [30] implies that the coagulation 
system is hyper-activated in the infected mice and that the endothelium is damaged by 
inflammation. Contrary to this, however, there was no apparent thrombosis (Figure S3), 
nor was there any evidence of platelet extravasation and aggregation in the space of Disse 
(Figure S3), which would otherwise be an indicator of damage to the sinusoidal endothe-
lium. Therefore, it is necessary to consider non-obstructive causes of sinusoidal dilation. 
For example, nitric oxide induces dilation of hepatic sinusoids in various conditions [34]. 
During experimental VL, nos2 expression was highly up-regulated in the infected liver 
(data not shown). In addition to nitric oxide, carbon monoxide is also involved in vasodi-
lation in the liver [35,36]. The infected liver also had up-regulated expression of hmox1 
gene (data not shown), which encodes the enzyme involved in production of carbon mon-
oxide. Future studies on nitric oxide and carbon monoxide, as well as other soluble factors, 
may help to elucidate the detailed mechanisms of sinusoidal dilation leading to hepato-
megaly during experimental VL. 
The fact that hepatomegaly is a major symptom of VL does not mean that this en-
largement is the only change in the liver during VL. To address other hepatic changes that 
may occur in L. donovani infection, serum biochemical analyses as well as histological anal-
yses were performed. One finding was the reduction of serum albumin in the infected 
mice (Figure 1). Low levels of albumin are also reported in human VL patients [37]. As 
production of albumin mainly occurs in the liver, the lower levels seen in infected mice 
and human VL patients indicate functional dysregulation of the liver by Leishmania infec-
tion. Additionally, there was a significant reduction in glycogen storage in the infected 
mice, suggestive of altered metabolism during experimental VL. Since IL-6 affects hepato-
cytes and causes insulin resistance [38], it is possible that infection-induced inflammation 
results in insulin resistance. However, steatosis was not observed in the infected liver, 
suggesting that insulin resistance is unlikely (Figure 2). Increased serum ALT in infected 
mice indicates a certain level of damage to hepatocytes by L. donovani infection (Figure 1). 
Nonetheless, histological analyses and TUNEL staining (data not shown) did not reveal 
enhanced necrosis or apoptosis of hepatocytes by the infection. This suggests that it is not 
a change in cell number, but rather, altered cell signaling in hepatocytes that is likely to 
account for the observed metabolic changes in the infected liver. 
In summary, we demonstrated that hepatomegaly in experimental chronic VL is due 
to edema associated with sinusoidal dilation. The dilation is not caused by either throm-
bosis or hepatocyte shrinkage, but may instead be caused by mechanisms unique to he-
patic sinusoids. Besides, L. donovani infection causes other functional changes in the liver, 
including storage of glycogen. Although there is no guarantee that our animal model 
surely reproduces liver pathology found in clinical VL cases, the experimental model pro-
vides some similarity to findings in human and dog VL. Therefore, it should be somewhat 
useful for understanding pathogenesis of hepatomegaly in chronic VL, because analyses 
of hepatomegaly kinetics in clinical VL cases requiring multiple biopsy collections are eth-
ically difficult, as any interventions for understanding the pathogenesis are unacceptable 
if they do not provide treatment. We believe that weakness of animal models of VL will 
be overcome by further collection of data in the experimental models coupled with careful 
comparisons with findings in clinical VL. 
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4. Materials and Methods 
4.1. Mice and Parasites 
Female BALB/cA mice and BALB/cA-nu/nu (nude) mice were purchased from Japan 
Clea, Tokyo, Japan. All mice were maintained under specific pathogen-free conditions. 
The mice were used for experiments at the age of 6–8 weeks. Leishmania donovani pro-
mastigotes (MHOM/NP/03/D10; a gift from the National BioResource Project at Nagasaki 
University [39]) were cultured in medium 199 (Thermo Fisher Scientific #12350-039, Wal-
tham, USA) supplemented with 10% heat-inactivated fetal bovine serum (Thermo Fisher) 
and 100 units/mL of penicillin and 100 μg/mL of streptomycin (Thermo Fisher) at 25 °C. 
4.2. Experimental Infection, Hematological Analyses, and Autopsy 
L. donovani promastigotes (passage number = 2) in late log or stationary phase were 
washed with phosphate-buffered saline (PBS: Nissui Pharm, Tokyo, Japan) by centrifuga-
tion at 1600× g for 10 min and were resuspended with PBS at the concentration of 1 × 108 
cells/mL. Mice were infected with 1× 107 L. donovani promastigotes by intravenous injec-
tion into the tail vein. After 12 or 24 weeks, cardiac puncture was performed on those mice 
under isoflurane anesthesia to collect the whole blood at the time of euthanasia, and the 
spleen and liver were then harvested. Impression smears of the spleen and liver were fixed 
for 5 min in methanol and stained for 25 min with 5% Giemsa solution (Merck KGaA, 
Parmstadt, Germany). Amastigotes were counted by microscopic observation of the 
stained smear at 1000× magnification, and Leishman-Donovan Units (LDU) were enumer-
ated as the number of amastigotes per 1000 host nuclei times the tissue weight in grams 
as performed in a previous study [40]. 
4.3. Periodic Acid Schiff (PAS) Staining 
The tissues collected at the time of sacrifice were fixed with Carnoy's solution com-
posed of 60% methanol, 30% chloroform, and 10% acetic acid for 48 hours and embedded 
in paraffin. Four-micrometer-thick sections were prepared from the paraffin-embedded 
tissues. The sections were dewaxed and treated with periodic acid for 5 minutes. Next, 
the sections were covered with Schiff’s reagent (MUTO PURE CHEMICALS CO.,LTD.) 
for 20 minutes and with sulfite water for 6 minutes for color development. Then, they 
were stained with Mayer’s hematoxylin solution (WAKO) for 90 sec and rinsed in running 
tap water for 5 min. For the quantification of glycogen, images were split into three colors 
using a Fiji plugin “Colour Deconvolution” (set vector at “H PAS”), purple signals were 
inverted to monochrome, and average color intensity was quantified. 
4.4. Oil Red-O Staining 
The tissues collected at the time of sacrifice were fixed with 10% buffered formalin 
(Sumitani Shoten Co., Ltd, Osaka, Japan). The fixed tissues were sent to Biopathology In-
stitute Co., Ltd (Oita, Japan) to make frozen sections and stain neutral fat with Oil red-O. 
For the quantification of triglyceride (TG) images were split to three colors using a plugin 
“Colour Deconvolution” (set vector at “RGB”), red signals were inverted to monochrome, 
and average color intensity was quantified. 
4.5. Histological Analyses 
The tissues collected at the time of sacrifice were fixed with 10% buffered formalin 
and then embedded in paraffin. Four-micrometer-thick liver sections were dewaxed and 
stained with hematoxylin and eosin (H&E) for histopathological and stereological anal-
yses. Digital images of hepatic tissue were obtained using a light microscope (Olympus 
BX-53, Tokyo, Japan) connected to a digital camera (Olympus DP73, Tokyo, Japan). Eight 
photomicrographs from H&E-stained sections (10×, 40× objective) were randomly ob-
tained for each mouse. For the stereological analysis, a test system of 192 or 768 points 
was used in a standard test area [41,42]. In sections stained with H&E, the points were 
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recorded in liver components (hepatocytes, sinusoidal capillaries, blood vessels, and oth-
ers). Area occupancy by individual components was calculated as the proportion of dots 
for the corresponding component from the total dots (Supplementary Figure 1). In addi-
tion, the number of nuclei in the micrograph was counted. Hepatocyte index, an indicator 
of the average size of hepatocytes, was calculated as below. 
Hepatocyte index =  
Hepatocyte index (%)
Number of hepatocyte nuclei
 (1) 
4.6. Immunohistochemical Analyses 
Immunohistochemical staining was performed to characterize the nuclei of prolifer-
ating cells. The tissues collected at the time of sacrifice were fixed with Carnoy's solution 
for 48 hours and embedded in paraffin. Paraffin-embedded tissues were dewaxed and 
boiled in 10 mM sodium citrate buffer (pH 6.0) for 20 min, followed by washing with tap 
water. Endogenous peroxidase was inactivated with 0.3% H2O2 in methanol for 30 min. 
After blocking with Block Ace (DS Pharm., Osaka, Japan), 2.5 μg/mL solution of anti-
mouse KI-67 antibody (Thermo Fisher #14-5698-80), 6 μg/mL solution of anti-mouse 
CD42b antibody (Abcam #ab183345) and 0.5 μg/mL solution of anti-mouse Ter119 anti-
body (BioLegend #116211) was applied to the sections of liver, and the sections were in-
cubated for 1 hour at room temperature and washed with PBS. Next, Histofine® Simple 
Stain Mouse MAX PO (Rat) (Nichirei, Tokyo, Japan), or Histofine® SAB PO(R) kit second 
antibody (Nichirei, Tokyo, Japan) followed by HRP-conjugated streptavidin (Nichirei, To-
kyo, Japan) was applied, and the sections were incubated for 1 h at room temperature and 
washed with PBS. After incubating with 3,3'-diaminobenzidine (DAB) substrate (Nichirei) 
to yield an enzymatic color change, the sections were counterstained with Mayer’s hema-
toxylin solution for 60 seconds and rinsed with tap water for 40 minutes. The pictures of 
each section were split to blue, blown, and green using a Fiji plugin “Colour Deconvolu-
tion” (set vector at “HDAB”), and the number of KI-67 positive and negative nuclei was 
counted. 
4.7. Measurement of Liver Water Content 
The cut tissue pieces (~100 mg of liver for each mouse) were placed at the bottom of 
a 1.5 mL centrifuge tube (BIOBIK #CF-0150) and dried at 90 °C for 24 hours using a CTU-
mini (TAITEC, Saitama, Japan). Of note, the dry weight did not change by further drying 
after 24 hours. The dry weight of the whole liver was calculated as the product of whole 
liver wet weight and the dry: wet weight ratio of the cut piece. The water content of each 
sample was calculated as below. 
Water content (%)  =  
Wet weight –  Dry weight
Wet weight
 ×  100 (2) 
4.8. Serum Biochemical Tests 
Serum was separated from the collected blood and analyzed for biochemical tests by 
Oriental Yeast Co., Ltd. (Tokyo, Japan). The following methods were used for the individ-
ual tests; total protein by biuret method, albumin by BCG method, globulin calculated as 
(total protein - albumin), AST by JSCC transferable method, ALT by JSCC transferable 
method, and TG by the GPO-HMMPS method. 
4.9. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 9 software package 
(GraphPad Software Inc., San Diego, CA). Results are presented as mean ± standard devi-
ation (SD). Either unpaired t test or two-way ANOVA coupled with Sidak's multiple 
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comparisons test was used for comparison of two independent groups, i.e. naive and L. 
donovani-infected mice. P values less than 0.05 were considered statistically significant. 
Supplementary Materials: The following are available online at www.mdpi.com/arti-
cle/10.3390/pathogens10111356/s1, Figure S1: Illustration of area occupancy analyses., Figure S2: 
Histological and immunohistochemical analyses on the liver of L. donovani-infected mice., Figure 
S3: No apparent obstruction of the sinusoids in the liver of L. donovani-infected mice. 
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